 SAN CARLOS, Calif., Feb. 10, 2022 GLOBE NEWSWIRE -- Vaxcyte, Inc. Nasdaq: PCVX, a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced that Company management will present at the 11th Annual SVB Leerink Global Healthcare Conference on Friday, February 18, 2022 at 2:20 p.m. ET 11:20 a.m. PT. 